Trifluridine/tipiracil (S 95005) is a combination medication used to treat colorectal cancer. It works by interfering with cancer cell growth and division. This medication is taken orally and helps slow down the progression of cancer in patients who have metastatic colorectal cancer.

Bevacizumab is a targeted therapy medication that works by blocking the formation of new blood vessels that feed tumors. By preventing the growth of these blood vessels, it helps slow down or stop cancer growth. It is given through an intravenous (IV) infusion.

Capecitabine is an oral chemotherapy medication that converts to an active form inside cancer cells. It works by interfering with cancer cell DNA production and growth. This medication is commonly used to treat various types of cancer, including colorectal cancer.

Metastatic colorectal cancer – A condition that begins as cancer in the colon or rectum and spreads to other parts of the body. The disease starts when cells in the large intestine begin to grow uncontrollably and form tumors. These cancer cells can break away from the original tumor and travel through the blood or lymph system to form new tumors in other organs. It most commonly spreads to the liver, but can also affect the lungs, bones, and other organs. The disease typically develops gradually over time, starting as small growths called polyps in the inner lining of the colon or rectum, which can eventually become cancerous and spread beyond the original site.